1.
Long-term safety assessment of live attenuated tetravalent dengue vaccines: Deliberations from a WHO technical consultation
by Bentsi-Enchill, Adwoa D
Vaccine, 2013, Vol.31 (23), p.2603-2609

2.
Understanding immune protection against tuberculosis using RNA expression profiling
by von Both, Ulrich
Vaccine, 2015, Vol.33 (40), p.5289-5293

3.

4.

5.

6.

7.
Effect of immune regulatory pathways after immunization with GMZ2 malaria vaccine candidate in healthy lifelong malaria-exposed adults
by Nouatin, Odilon
Vaccine, 2020, Vol.38 (27), p.4263-4272

8.
Long-term mucosal T cell activation and homing phenotypes in recipients of an Ad5-vectored HIV vaccine
by Curlin, Marcel E
Vaccine, 2020, Vol.38 (36), p.5814-5821

9.

10.
Penton-dodecahedron of fowl adenovirus serotype 4 as a vaccine candidate for the control of related diseases
by Wang, Xinglong
Vaccine, 2019, Vol.37 (6), p.839-847

11.
An in vitro functional assay to measure the biological activity of TB vaccine candidate H4-IC31
by Ming, Marin
Vaccine, 2019, Vol.37 (22), p.2960-2966

12.
Respiratory syncytial virus suppression of the antiviral immune response: Implications for evaluation of candidate vaccines
by Roberts, Norbert J
Vaccine, 2019, Vol.37 (51), p.7451-7454

13.

14.

15.
Ki-67 expression reveals strong, transient influenza specific CD4 T cell responses after adult vaccination
by Li, Xi
Vaccine, 2012, Vol.30 (31), p.4581-4584

16.
Humoral and cellular immune memory response 12 years following single dose vaccination against hepatitis A in Argentinian children
by Urueña, A
Vaccine, 2022, Vol.40 (1), p.114-121
